Notice of Effectiveness · EFFECT
Lexaria Bioscience Corp.
LEXXNASDAQEQUITYCurrent
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-10-13
- Effective time (as filed)
- 17:00:00
- Form
- S-3
Registrant 1
- Registrant
- Lexaria Bioscience Corp.
- Registrant CIK
- 0001348362
- File number
- 333-299257
Company context
Lexaria is a biotechnology company dedicated to the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (“APIs”) using our patented DehydraTECHTM drug delivery technology. DehydraTECH combines APIs with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods.